TP53 and colonic neoplasm: In contrast, these concentrations of oxaliplatin had no effect on clonogenicity of HCT116 p53−/− cells (Figure 7D), further demonstrating that inactivation of p53 in colon cancer cells results in a significant protection from oxaliplatin cytotoxicity.